EP3340989
MDM2 INHIBITORS AND COMBINATIONS THEREOF
:
EP einkaleyfi: Þýðing ekki lögð inn:
24.8.2016:
16.8.2023:
16760803.3
:
23.8.2036
:
MDM2 INHIBITORS AND COMBINATIONS THEREOF
24.8.2016
16.8.2023
:
Novartis AG:
Lichtstrasse 35, 4056 Basel, CH
:
HALILOVIC, Ensar:
Cambridge, Massachusetts 02139, US
:
CAPONIGRO, Giordano:
Cambridge, Massachusetts 02139, US
:
HORN-SPIROHN, Thomas:
Cambridge, Massachusetts 02139, US
:
LEHAR, Joseph:
Cambridge, Massachusetts 02139, US
:
201562211080 P:
28.8.2015:
US
:
201562243337 P:
19.10.2015:
US
:
201562250574 P:
4.11.2015:
US
:
IB2016055050:
24.8.2016
:
A61K 31/496, A61K 31/506, A61K 31/519, A61K 31/5375, A61P 35/00